Welcome to Merz North America

Merz North America is a specialty healthcare company dedicated to the development and marketing of innovative quality products for physicians and patients across the US. Our products are distributed through two divisions: Aesthetics and Neurosciences.


Merz Showcases Data Across Multiple Injectable and Device Products at American Academy of Dermatology Annual Meeting

Merz Americas today announced the presentation of data, including one oral presentation, from studies of its aesthetics products, including Xeomin® (incobotulinumtoxinA), Ultherapy®, Radiesse® and the Cellfina® System, at the American Academy of Dermatology (AAD) annual meeting, March 1-5, in Washington, DC.

Read More

Merz and Christie Brinkley Inspire Women to Redefine Life’s Big Moments Through New “Milestones of Me” Campaign Featuring Ultherapy®

Merz Americas is partnering with supermodel, actress and entrepreneur, Christie Brinkley, to launch a new campaign, “Milestones of Me,” which encourages women to celebrate the moments, big or small, that have made them who they are today. The campaign kicks off in honor of Christie’s 65th birthday, and inspires women to not shy away from wanting to look and feel their best as they celebrate new milestones. At nearly 65, one of the ways Christie continues to look and feel great is with Ultherapy®. As the only FDA-cleared, non-invasive procedure that lifts and tightens the neck, chin and brow area, and improves lines and wrinkles on the chest, Ultherapy stimulates natural collagen and elastin, without any downtime.

Read More

Merz Encourages Women to Smash through Labels and Judgment with Disruptive New DTC Campaign for XEOMIN® (incobotulinumtoxinA)

Merz Americas announced today the launch of a new advertising campaign for XEOMIN® (incobotulinumtoxinA) called “Later Haters,” which calls for women to “X out” judgment, stop apologizing for caring about how they look and put an end to feeling guilty about their self-care routines. XEOMIN is the latest botulinum toxin type A approved by the U.S. Food and Drug Administration (FDA) to temporarily improve the look of moderate to severe frown lines between the eyebrows (glabellar lines) in adults.

Read More